English

Benzinga - Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by

Today News

03

Tater Debate: 14 Senators Come Together To Mash USDA's Grainy Ideas On Potatoes

www.benzinga.com

Fourteen senators are pushing back against a potential reclassification of potatoes from vegetables to grains by the US Department of Agriculture and Department of Health and Human Services.

02

'Sick Man' And 'Sociopath' — Larry David Unleashes Blunt Criticism Of Donald Trump: 'He's A Little Baby'

www.benzinga.com

Larry David, the creator of “Curb Your Enthusiasm” and “Seinfeld”, expressed his strong disapproval of former President Donald Trump in a recent episode of CNN’s “Who’s Talking to Chris Wallace?”

Joe Biden Joins Forces with Obama, Clinton in $25M NY Fundraiser; Trump Planning To Surpass With $33M Goal

www.benzinga.com

Joe Biden has teamed up with former presidents Barack Obama and Bill Clinton for a fundraiser in New York.

'Rabid Trump Hater' Says Ex-President About Daughter Of Hush Money Judge In Fresh Attack

www.benzinga.com

Former President Donald Trump has initiated a verbal onslaught against the daughter of the judge who will be presiding over his impending criminal trial in New York.

Thursday, Mar 28

23

Here's How Much $100 Invested In Monster Beverage 10 Years Ago Would Be Worth Today

www.benzinga.com

Monster Beverage (NASDAQ:MNST) has outperformed the market over the past 10 years by 6.99% on an annualized basis producing an average annual return of 17.71%. Currently, Monster Beverage has a market capitalization of $62.00 billion.

$1000 Invested In This Stock 20 Years Ago Would Be Worth $19,000 Today

www.benzinga.com

Arch Capital Group (NASDAQ:ACGL) has outperformed the market over the past 20 years by 8.16% on an annualized basis producing an average annual return of 16.03%. Currently, Arch Capital Group has a market capitalization of $34.59 billion.

Demystifying Apple: Insights From 21 Analyst Reviews

www.benzinga.com

DateFirmActionFromTo Mar 2022BarclaysMaintainsEqual-Weight Feb 2022Tigress FinancialMaintainsStrong Buy Jan 2022Credit SuisseMaintainsNeutral

$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today

www.benzinga.com

Vertiv Hldgs (NYSE:VRT) has outperformed the market over the past 5 years by 39.36% on an annualized basis producing an average annual return of 52.2%. Currently, Vertiv Hldgs has a market capitalization of $31.14 billion.

Cracking The Code: Understanding Analyst Reviews For Dover

www.benzinga.com

DateFirmActionFromTo Jan 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Morgan StanleyMaintainsEqual-Weight Jan 2022OppenheimerUpgradesPerformOutperform

$1000 Invested In This Stock 15 Years Ago Would Be Worth $27,000 Today

www.benzinga.com

Heico (NYSE:HEI) has outperformed the market over the past 15 years by 11.56% on an annualized basis producing an average annual return of 24.51%. Currently, Heico has a market capitalization of $26.43 billion.

22

Gold Royalty Projects Revenue To Double; Universal Stainless Sees Record Sales; Atlas Lithium Gets $30M And More: Thursday's Top Mining Stories

www.benzinga.com

Top Stories: GROY reports lower than expected Q4 revenue, USAP sees record sales in Q4 and 2023, ATLX secures $30M investment, XPL discovers high-grade gold zone at Golden Crest project.

$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today

www.benzinga.com

ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 5.16% on an annualized basis producing an average annual return of 15.88%. Currently, ResMed has a market capitalization of $29.13 billion.

Gold Prices Rise To All-Time Highs, Mark Best Month In 4 Years: Mining Stocks Rally As Traders Anticipate Windfall Gains

www.benzinga.com

Gold prices hit new high of $2,220/oz as central banks anticipate rate cuts. Gold miners' stocks also surge, with VanEck's GDX up 20%.

Cannabis Finance Company Silver Spike Announces Solid 2023 Gains

www.benzinga.com

Discover Silver Spike Investment Corp.'s robust 2023 financial performance, strategic acquisitions, and dividend news.

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression

www.benzinga.com

Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley's novel formulation of 5-MeO-DMT in Treatment Resistant Depression (TRD.)

Building Around Novelty, Risks Worth Taking – Cannabis Veterans Reveal Secretes To Dominating Midwestern Marijuana Market

www.benzinga.com

There is an ongoing sentiment in the U.S. that if the Midwest accepts new trends, they’ll be accepted across the nation. In the case of cannabis, with Midwest acceptance it will be deemed non-controversial anymore, writes New Frontier’s…

Where Fastly Stands With Analysts

www.benzinga.com

DateFirmActionFromTo Feb 2022Raymond JamesUpgradesOutperformStrong Buy Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022KeybancInitiates Coverage OnSector Weight

Analyst Scoreboard: 12 Ratings For Northern Oil & Gas

www.benzinga.com

DateFirmActionFromTo Mar 2022B of A SecuritiesDowngradesBuyNeutral Mar 2022RBC CapitalMaintainsOutperform Dec 2021B of A SecuritiesUpgradesNeutralBuy

Expert Outlook: Equinix Through The Eyes Of 12 Analysts

www.benzinga.com

DateFirmActionFromTo Feb 2022Deutsche BankMaintainsBuy Feb 2022BMO CapitalMaintainsMarket Perform Feb 2022Cowen & Co.MaintainsMarket Perform